What's in US Oncology Research's pipeline?

US Oncology Research has 3 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with US Oncology Research's portfolio?

Top competitors by shared drug class: Actuate Therapeutics Inc., American Genomics, LLC, City of Hope Medical Center, Cooperative Study Group A for Hematology, Genzyme, a Sanofi Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/us-oncology-research.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

US Oncology Research — Portfolio Competitive Intelligence Brief

US Oncology Research pipeline: 0 marketed, 0 filed, 0 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actuate Therapeutics Inc. · 1 shared drug class
American Genomics, LLC · 1 shared drug class
City of Hope Medical Center · 1 shared drug class
Cooperative Study Group A for Hematology · 1 shared drug class
Genzyme, a Sanofi Company · 1 shared drug class
Hospices Civils de Lyon · 1 shared drug class
Innovent Biologics (Suzhou) Co. Ltd. · 1 shared drug class
Osaka Medical Center for Cancer and Cardiovascular Diseases · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for US Oncology Research:

Cite this brief

Drug Landscape (2026). US Oncology Research — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/us-oncology-research. Accessed 2026-05-16.